RecruitingPhase 4NCT03346772
Study of Immune Responses to Influenza Vaccination
Sponsor
University of Pennsylvania
Enrollment
75 participants
Start Date
Oct 20, 2017
Study Type
INTERVENTIONAL
Summary
Better understanding of the immune responses to influenza vaccination is needed in order to understand situations of poor vaccine response. Adults will receive influenza vaccination and then have peripheral blood drawn at pre-defined intervals in order to study the lymphocyte responses.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Community-dwelling adults able to provide consent who need influenza vaccination for standard of care
Exclusion Criteria6
- febrile illness at time of vaccination
- active malignancy
- use of immunosuppressing medications
- blood donation in the past 60 days
- influenza vaccinated during the preceding 6 months
- allergic reactions to influenza vaccination
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BIOLOGICALInfluenza vaccination
Adults will receive one intramuscular dose of seasonal quadrivalent inactivated influenza vaccine, as indicated for standard of care.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03346772